Font Size:
a
A
A
Keyword [Partition survival]
Result: 1 - 1 | Page: 1 of 1
1.
Economic Evaluation Of Ensartinib For Patients With Anaplastic Lymphoma Kinase-positive Non-small-cell Lung Cancer In China
<<First
<Prev Next>
Last>>
Jump to
